THC Antibody (C29): sc-58054

THC Antibody (C29) is a mouse monoclonal IgG1 antibody that detects THC protein through enzyme-linked immunosorbent assay (ELISA). Anti-THC antibody (C29) is available as a non-conjugated isotype antibody. Tetrahydrocannabinol (THC) is the primary psychoactive component of the Cannabis plant, playing a crucial role in the plant′s defense mechanisms against herbivores and pathogens. The structure of THC, characterized by its unique arrangement of carbon rings and functional groups, is essential for its interaction with cannabinoid receptors, particularly the CB1 receptor in the brain. This interaction is responsible for the diverse pharmacological effects of THC, including analgesia, relaxation, and alterations in sensory perception. Additionally, the structural properties of THC contribute to its ability to absorb ultraviolet light, providing protection to the plant from harmful radiation. Research into THC′s therapeutic potential has revealed its possible benefits in treating conditions such as multiple sclerosis, Parkinson′s disease, cancer, and Alzheimer′s disease, although its classification as an illegal substance in the United States poses significant challenges for further investigation.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

THC Antibody (C29) References:

1. The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans.  |  Carlini, EA. 2004. Toxicon. 44: 461-7. PMID: 15302527
2. Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.  |  Roberts, JD., et al. 2006. Eur J Pharmacol. 530: 54-8. PMID: 16375890
3. Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.  |  Walther, S., et al. 2006. Psychopharmacology (Berl). 185: 524-8. PMID: 16521031
4. Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate.  |  Yu, YZ., et al. 2011. Vaccine. 29: 5978-85. PMID: 21718736
5. Evaluation of a recombinant tetanus toxin subunit vaccine.  |  Liu, FJ., et al. 2020. Toxicon. 187: 75-81. PMID: 32889026
6. Identification of acetylcholinesterase inhibitors and stability analysis of THC@HP-β-CD inclusion complex: A comprehensive computational study.  |  Mostefai, N., et al. 2025. Talanta. 286: 127370. PMID: 39753079
7. Delta-1-tetrahydrocannabinol: structure of a major metabolite.  |  Nilsson, IM., et al. 1970. Science. 168: 1228-9. PMID: 5442709
8. Treatment of human spasticity with delta 9-tetrahydrocannabinol.  |  Petro, DJ. and Ellenberger, C. 1981. J Clin Pharmacol. 21: 413S-416S. PMID: 6271839
9. Tetrahydrocannabinol potentiates reserpine-induced hypokinesia.  |  Moss, DE., et al. 1981. Pharmacol Biochem Behav. 15: 779-83. PMID: 6273940
10. Tetrahydrocannabinol for tremor in multiple sclerosis.  |  Clifford, DB. 1983. Ann Neurol. 13: 669-71. PMID: 6309074
11. Medicinal applications of delta-9-tetrahydrocannabinol and marijuana.  |  Voth, EA. and Schwartz, RH. 1997. Ann Intern Med. 126: 791-8. PMID: 9148653
12. Delta-9-tetrahydrocannabinol (THC) fails to stimulate consumption of a highly palatable food in the rat.  |  Graceffo, TJ. and Robinson, JK. 1998. Life Sci. 62: PL85-8. PMID: 9489514

Monoclonal antibodies for mammalian and non-mammalian protein targets represent essentially all targets covered by polyclonal antibodies. Over 8,300 of our antibodies are offered as ImmunoCruz^® conjugates which eliminates the need for a secondary antibody.

Santa Cruz Biotechnology antibodies have over 360,000 research citations. Anti-THC Antibody (C29) has 0 citations in a variety of scientific publications.

Primary antibodies for mammalian target proteins are recommended for the detection of a range of mammalian species, primarily of mouse, rat and human species. Many mammalian antibodies are also ideal for veterinary research and reactive with ovine, porcine, caprine, feline, canine, bovine and equine protein targets. Santa Cruz Biotechnology primary monoclonal antibodies are suitable for laboratory research applications and are not intended for diagnostic or therapeutic use.

THC Antibody (C29) Specifications

Alternate Product Name: THC

Product Clone Name: C29

Classification: Primary Antibody

Clonality: Monoclonal Antibody

Antibody Isotype: IgG₁

Amino Acids:

Epitope Target: 8-THC

Epitope Species:

Product Reactivity/Detection: THC (Cannabinoids) and metabolites

Species Reactivity/Detection: NSR

Additional Mammalian Reactivity: N/A

Additional Non-Mammalian Reactivity: N/A

Applications: ELISA

Vialing Information: Each vial contains 100 µg IgG₁ in 1.0 ml of PBS with < 0.1% sodium azide and 0.1% gelatin

Research Citations: 0 citations in various scientific publications

Available Conjugates/Forms for THC Antibody (C29): N/A